Today: January 17, 2019, 6:42 am

BIOCAD expects to make 50% of total revenue from export activities by 2023 2018-10-12 07:58:02

The international pharmaceutical trade fair CPhI Worldwide held October 9-11, 2018 in Madrid (Spain), lays a solid cornerstone of the growth in exports.

BIOCAD expects to make 50% of total revenue from export activities by 2023

Irina Kenyukhova
+7(812)3804933, ext. 632

The biotechnology company BIOCAD expects CPhI Worldwide to ensure a favorable climate for signing new distribution agreements with representatives of the pharmaceutical industries of Greece, UAE and Mexico. BIOCAD has signed an agreement with Greek company WinMedica have already expressed their interest in the adalimumab biosimilar indicated for the treatment of some autoimmune diseases; its dossier is currently being prepared for submission for registration in the European Union in 2021. Expected that clinical trial in EU will start already next year. BIOCAD is going to export more than 115000 packages of the drug product to Greece and Cyprus in the first five years. At CPhI, BIOCAD has reached also a supply agreement with one of the largest pharmaceutical manufacturers in the Middle East and Africa, Julphar. Medicines produced by BIOCAD are competitive in their effectiveness, as well as the price. Therefore, the presence of Russian innovative drugs in the United Arab Emirates will help make important biological therapies widely accessible to patients. The technology transfer agreement have signed between BIOCAD and a Mexican company Psicofarma S.A. De C.V. for three therapeutic monoclonal antibodies, trastuzumab, rituximab and bevacizumab. BIOCAD expects the turnover of 198 mil. $ from European countries and approximately 516 mil. $ from Asia, Latin America and MENAT region by 2023.

According to BIOCAD’s estimations export revenues will increase by 80%

“Today, we owe the exports core to North Africa, India and Asia,” says Dmitry Morozov, BIOCAD’s CEO, “but we expect that soon after receiving marketing authorizations in Latin America, including Argentina, Colombia, and in MENA countries, primarily Egypt, these regions will challenge the leadership. We also expect high sales after completion of authorization procedures in the EU countries, and then in Japan and China.”

Since September 2017, the company has been actively working to localize BIOCAD production in Turku, Finland. Activities planned for 2019 include completion of the manufacturing site design, setting up a network of contact analytical laboratories, initiation of clinical studies in the EU countries, purchase of materials and services for the cleanrooms of the new facility. The first sales in Finland are anticipated in 2022.

BIOCAD has signed new distribution agreements with representatives of the pharmaceutical industries of Greece, UAE and Mexico.

Press Information

Published by
Hossam Abdel-Kader
+43 1 9582319

# 396 Words
Related Articles
More From The Author
TGS and Schlumberger Announce New Multiclient Nodal [..]
ASKER, NORWAY (12 October 2018) - TGS and Schlumberger today announced a new multiclient nodal seismic project in the U.S. [..]
American Lending Center Grows EB-5 Business with [..]
American Lending Center (ALC), one of the United States' leading EB-5 regional centers, joined international industry influencers in [..]
EDOM Establishes New Branch Office in South [..]
EDOM Technology (TSE: 3048), Asia’s best distribution and solutions provider, announces the opening of new branch office in [..]
Crossvale Showcased A Groundbreaking Auto-scaling Product [..]
CloudBalancer for Red Hat OpenShift complements Red Hat’s enterprise Kubernetes platform, Red Hat OpenShift Container Platform. [..]
A.M. Best Upgrades Credit Ratings of General [..]
A.M. Best has upgraded the Financial Strength Rating to A- (Excellent) from B++ (Good), the Long-Term Issuer Credit Rating to [..]
More From Business
3,300+ Finance, Business Leaders Join Asian Financial [..]
HONG KONG, Jan 16, 2019 - (ACN Newswire) - More than 3,300 financial policymakers, financial elites and business leaders attended [..]
The Executive Talk: Chememan PCL (SET:CMAN)
BANGKOK, Jan 15, 2019 - (ACN Newswire) - Chememan PCL (SET:CMAN) Chief Executive Officer, Mr. Adisak Lowjun discusses the company's [..]
Sapphire's Subsidiary Awarded EPC Contract of RMB [..]
SINGAPORE, Jan 15, 2019 - (ACN Newswire) - SGX Mainboard-listed Sapphire Corporation Limited ("Sapphire", and together [..]
Hong Kong Investment Promotion chief visits London [..]
HONG KONG, Jan 14, 2019 - (ACN Newswire) - The Director-General of Investment Promotion of the Hong Kong Special Administrative [..]
Wildfire Design & Build Receives 2018 Best [..]
NAPA December 13, 2018 -- Wildfire Design & Build has been selected for the 2018 Best of Napa Award in [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.